Ebru Temiz
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Enzyme function and inhibition
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- RNA Research and Splicing 4
- Circular RNAs in diseases 4
- Enzyme function and inhibition 4
- Natural product bioactivities and synthesis 3
- RNA modifications and cancer 3
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Co-authors
- İsmail Koyuncu (25 shared papers)Ataman Gönel (5 shared papers)Abdürrahim Koçyiğit (3 shared papers)Mustafa Durgun (4 shared papers)Claudiu T. Supuran (4 shared papers)Sercan Ergün (6 shared papers)Emel Şahın (1 shared paper)Esra Bozgeyi̇k (6 shared papers)
In The Last Decade
Ebru Temiz
40 papers receiving 323 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 105
- Molecular Biology 204
- Biochemistry 13
- Complementary and alternative medicine 17
- Organic Chemistry 57
Countries citing papers authored by Ebru Temiz
This map shows the geographic impact of Ebru Temiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ebru Temiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ebru Temiz more than expected).
Fields of papers citing papers by Ebru Temiz
This network shows the impact of papers produced by Ebru Temiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ebru Temiz. The network helps show where Ebru Temiz may publish in the future.
Co-authors
The 25 scholars most cited alongside Ebru Temiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 32 | |
| 2 | 2018 | 28 | |
| 3 | 2021 | 23 | |
| 4 | 2014 | 19 | |
| 5 | 2018 | 19 | |
| 6 | 2014 | 18 | |
| 7 | 2018 | 18 | |
| 8 | 2022 | 15 | |
| 9 | 2016 | 15 | |
| 10 | 2022 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2020 | 11 | |
| 13 | 2021 | 9 | |
| 14 | 2016 | 9 | |
| 15 | 2024 | 8 | |
| 16 | 2014 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2017 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 6 |
About Ebru Temiz
Ebru Temiz is a scholar working on Molecular Biology, Cancer Research, Organic Chemistry, Surgery and Nutrition and Dietetics, having authored 42 papers that have together received 326 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), RNA Research and Splicing (4 papers), Circular RNAs in diseases (4 papers), Enzyme function and inhibition (4 papers), Natural product bioactivities and synthesis (3 papers), RNA modifications and cancer (3 papers) and Essential Oils and Antimicrobial Activity (3 papers). The work is most often cited by research in Cancer Research (105 citations), Molecular Biology (204 citations), Biochemistry (13 citations), Complementary and alternative medicine (17 citations) and Organic Chemistry (57 citations). Ebru Temiz has collaborated with scholars based in Türkiye, Italy and Belgium. Frequent co-authors include İsmail Koyuncu, Ataman Gönel, Abdürrahim Koçyiğit, Mustafa Durgun, Claudiu T. Supuran, Sercan Ergün, Emel Şahın, Esra Bozgeyi̇k, Serdar Öztuzcu and İbrahim Bozgeyik. Their work appears in journals such as Molecular Biology Reports, Gene, Biochemical and Biophysical Research Communications, Anti-Cancer Agents in Medicinal Chemistry and Journal of Enzyme Inhibition and Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.